Condition
Thyroid Associated Ophthalmopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Thyroid Associated Ophthalmopathy clinical trials that are recruiting, at sites in 5 countries (most in China (4), Sweden (1), Norway (1)). By phase: Phase 3 (2), Phase 2 (1), Phase 2/3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 5Countries
Newest Thyroid Associated Ophthalmopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Precise diagnosis and treatment system for thyroid-associated eye disease | — | Hangzhou, Zhejiang | Recruiting | Aug 15, 2025 |
| Combining Tocilizumab and Flupentixol-Melitracen for Thyroid Eye Disease Treatment | Phase 4 | Shanghai, Shanghai Municipality | Recruiting | Apr 15, 2025 |
| Multiparametric prediction models for moderate to severe thyroid-associated eye disease | — | Shanghai, Shanghai Municipality | Recruiting | Sep 19, 2024 |
| Comparing short and standard radiation therapy for thyroid eye disease | Phase 3 | Bangkok Noi | Recruiting | May 1, 2024 |
| Evaluating linsitinib for thyroid eye disease | Phase 2/3 | Miami, Florida and 1 other locations | Recruiting | Nov 1, 2023 |
| Evaluating doxycycline for treating Thyroid Associated Ophthalmopathy | — | Guangzhou, Guangdong | Recruiting | Nov 8, 2021 |
| Comparing Sirolimus and Corticosteroids for Thyroid Eye Disease | Phase 2 | Bergen, Hordaland | Recruiting | Jun 23, 2021 |
| Treatment for Graves' ophthalmopathy using simvastatin | Phase 3 | Malmö | Recruiting | Apr 27, 2017 |
All recruiting trials (8)
-
Precise diagnosis and treatment system for thyroid-associated eye disease
This project will test whether a deep-learning system using eye images and exams can automatically diagnose, stage, and help plan treatment for people with thyroid-associated ophthalmopathy.
-
Combining Tocilizumab and Flupentixol-Melitracen for Thyroid Eye Disease Treatment
This study is testing if combining two medications, Tocilizumab and Flupentixol-Melitracen, can help people with thyroid eye disease feel better and improve their eye symptoms.
-
Multiparametric prediction models for moderate to severe thyroid-associated eye disease
This project will try to build and test combined imaging and lab-marker models to predict outcomes in adults with moderate to severe thyroid-associated ophthalmopathy.
-
Comparing short and standard radiation therapy for thyroid eye disease
This study is testing if fewer sessions of radiation therapy can help people with moderate to severe thyroid eye disease just as well as the standard number of sessions, while also making their experience better.
-
Evaluating linsitinib for thyroid eye disease
This study is testing if a new drug called linsitinib can help people with moderate to severe thyroid eye disease who haven't improved with other treatments.
-
Evaluating doxycycline for treating Thyroid Associated Ophthalmopathy
This study is testing if doxycycline can help people with Thyroid Associated Ophthalmopathy feel better and improve their eye symptoms.
-
Comparing Sirolimus and Corticosteroids for Thyroid Eye Disease
This study tests whether Sirolimus can be a safer and more effective treatment for people with moderate-to-severe thyroid eye disease compared to traditional corticosteroids.
-
Treatment for Graves' ophthalmopathy using simvastatin
This study is testing if simvastatin can help people with mild to moderate Graves' ophthalmopathy avoid getting worse.
Related topics
Quick answers
How many Thyroid Associated Ophthalmopathy clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (4 trials), Sweden (1 trial), Norway (1 trial), Thailand (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1, Phase 2/3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.